The analysis supports making dapagliflozin part of standard inpatient HF pathways rather than postponing it until discharge.

Seismic Pharma, a newly formed biopharmaceutical company, today announced its launch and initial financing led by Panacea Capital. The company has been formed to advance a portfolio of clinically ...

A multicenter study has identified a potential new treatment for acute heart failure, a leading cause of hospitalization and death. A multicenter study led by Vanderbilt University Medical Center ...

Among stable, relatively low-risk patients who had previously suffered a heart attack, discontinuing beta-blockers after at ...

Know the key differences, early symptoms, causes and treatment options to avoid confusion and ensure timely medical care in ...

Why has a 64-year-old man become increasingly short of breath over the past 2 weeks? That's what Sandra K. Rabat, DO, of A.T. Still University School of Osteopathic Medicine in Mesa, Arizona, and ...

CHICAGO, IL—Spironolactone given to patients who have undergone PCI following an acute myocardial infarction has no impact on death from cardiovascular causes, or on a range of cardiovascular events ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

Khaberni - The health authorities in Japan have approved innovative stem cell-based treatments for Parkinson's disease and acute heart failure, a step that could represent a major shift in ...

A Connecticut cardiac surgeon was so inspired by the “grit” and “resilience” of a patient in heart failure that he’s invented a medical device so others won’t need so much of those those rare ...